China Bicalutamide Market Report 2021: AstraZeneca's Casodex Accounted for More than 70% Share of China's Bicalutamide Market in 2020 - Forecast to 2025
07 déc. 2021 06h33 HE
|
Research and Markets
Dublin, Dec. 07, 2021 (GLOBE NEWSWIRE) -- The "Research Report on China's Bicalutamide Market, 2021-2025" report has been added to ResearchAndMarkets.com's offering. Bicalutamide, originally...